Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 17Sarcoma 6Gastrointestinal 4Lymphoid 3Genitourinary 3Dermatologic 3Other hematologic neoplasm 2Thoracic 1Plasma cell 1Gynecologic 1Classical hematology 1Breast 1

Conditions

Leukemia, Myeloid, Acute 30Anemia, Refractory, with Excess of Blasts 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Myelodysplastic Syndromes 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 19Multiple Myeloma 16Hodgkin Disease 16Anemia, Aplastic 16Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 15Myeloproliferative Disorders 12Lymphoma 11Primary Myelofibrosis 10Hematologic Neoplasms 10Leukemia 9Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelomonocytic, Chronic 5Polycythemia Vera 4Immunologic Deficiency Syndromes 4Hemoglobinopathies 4Fanconi Anemia 4Burkitt Lymphoma 4Blast Crisis 4Anemia, Sickle Cell 4Anemia, Refractory 4Anemia 4Thalassemia 3Recurrence 3

Interventions

Melphalan 3Busulfan 3Antilymphocyte Serum 3fludarabine phosphate 2Thrombopoietin 2Radiotherapy 2Methylprednisolone 2Cyclophosphamide 2thymoglobulin 1fosphenytoin 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Therapeutics 1Phenytoin 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Carboplatin 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × fludarabine × Classical hematology × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡